Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 11:42 PM
Ignite Modification Date: 2025-12-25 @ 9:34 PM
NCT ID: NCT00708851
Description: Adverse events were reported directly by the subject to the principal investigator, who then informed the responsible party: NeoStrata Co., Inc.
Frequency Threshold: 0
Time Frame: Adverse events for this study were monitored and documented throughout the entire 12 week study.
Study: NCT00708851
Study Brief: NB-UVB Phototherapy With and Without Topical LCD Treatment: a Bilateral Pilot Study
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
NB-UVB Alone NB-UVB Alone NB-UVB Light Device (311-315 nm): NB-UVB Phototherapy: 3 light exposures / week None None 0 12 3 12 View
LCD+NB-UVB LCD+NB-UVB LCD Solution with NB-UVB Phototherapy: LCD Solution: 2 applications / day NB-UVB Phototherapy: 3 light sessions / week None None 0 12 3 12 View
Serious Events(If Any):
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Erythema SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders None View
Erythema SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders None View